| Report ID |
98371 |
| Drug Identification Number |
02049481 |
| Brand name |
NOVAHISTEX DH |
| Common or Proper name |
Novahistex DH |
| Company Name |
SANOFI-AVENTIS CANADA INC |
| Market Status |
CANCELLED POST MARKET |
| Active Ingredient(s) |
PHENYLEPHRINE HYDROCHLORIDE
HYDROCODONE BITARTRATE |
| Strength(s) |
20MG
5MG |
| Dosage form(s) |
SYRUP |
| Route of administration |
ORAL |
| Packaging size |
100ml |
| ATC code |
R05DA |
| ATC description |
COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
| Reason for discontinuation |
Business reasons |
| Anticipated discontinuation date |
2020-03-31 |
| Actual discontinuation date |
|
| Remaining supply date |
2020-03-31 |
| Discontinuation status |
To be discontinued |
| Discontinuation decision reversal |
No |
| Information on remaining supply |
|
| Company comments |
|
| Health Canada comments |
|
| Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |
